Protein; Antibody; Peptide
Adherent & suspension cells grown in presence of serum
|Number of transfection|
0.4 ml of PULSin® delivery reagent is sufficient to perform 25 delivery experiments in 6-well plates and 100 experiments in 24-well plates
Store PULSin® at 5 °C ± 3°C. Do not freeze.
Hepes Buffer (20mM) for protein dilution; R-Phycoerythrin used as a positive control
The delivery of protein and antibody using PULSin® represents a powerful approach for functional studies. For example, PULSin® enables you to study lethal proteins by controlling the level and time course of protein delivery into the cells. Similarly, delivery of blocking antibodies may provide additional information to traditional RNA interference experiments*. With PULSin® you can target intracellular proteins with antibodies in living cells without fixation step.
* G. Cassinelli et al. (2006). Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI-1, Mol Cancer Ther 5:9, 2388-2397.
|Reference number||Amount of reagent||Positive control (R-phycoerythrin)||Hepes dilution buffer|
|101000010||PULSin® 0.4 mL||20 µg||20 ml|
Efficient delivery of proteins/antibodies and peptides to the cytoplasm
PULSin® is able to deliver R-phycoerythrin, a fluorescent protein (240 kD), to the cytoplasm of up to 98% cells. As shown in Figure 1, the protein is evenly distributed in the cytoplasm and excluded from the nucleus due to its large size.
Fig 1: PULSin®-mediated intracellular delivery of R-phycoerythrin to NIH-3T3 cells. R-phycoerythrin (1 µg) is complexed with 4 µl of PULSin® for 15 min and added to NIH-3T3 cells in a 24-well plate. Live cells are observed by fluorescence microscopy after 16 h.
Antibodies are also successfully delivered to HeLa cells and able to recognize their target protein inside the cytoplasm.
For example, PULSin® permits the delivery of FITC-labeled anti-alpha-tubulin to the cytoplasm of 85% HeLa cells (Fig.2). Similarly, anti-giantin Alexa Fluor® 488 is delivered to the cytoplasm of 98% of live HeLa cells, labeling the Golgi apparatus (Fig.3).
Fig 2: Delivery of a fluorescein-conjugated anti-alpha-tubulin antibody with PULSin® to HeLa cells.
Fig 3: Golgi labeling (green) of HeLa cells 24 h after delivery of 1 µg Alexa Fluor® 488 anti-Giantin using PULSin®.
Plasma membrane is stained with ConA-rhodamine. Cells are observed by confocal microscopy.
Peptides are biomolecules acting with high specificity at low concentrations. The delivery of substrate, inhibitor, modulator, or blocking peptides into cell allows protein function studies as well as the development of therapeutic approaches. PULSin® is able to successfully deliver Streptococcus TPE B epitope into HeLa cells (Fig. 4).
Fig 4: Delivery of Pep-A (Streptococcus TPE B epitope, 16 aa), into HeLa cells. Complexes are formed with Pep-A (1 µg, lissamine-rhodamine derivative, Sigma) and PULSin® (4 µl). Observation is carried out 16 h post-delivery.
Other proteins, antibodies and peptides can also be delivered to cells using PULSin® (Table 1).
Table 1: Examples of proteins, antibodies and peptides delivered to cells using PULSin®
PULSin® is easy to use and fast
PULSin® will save you time and efforts compared to other techniques using viral transduction or chemical conjugation. PULSin® reagent is ready-to-use and provided with a dilution buffer and a fluorescent control protein (R-phycoerythrin).
The protocol is fast: simply add the reagent to the protein, incubate and add to the cells.
Cells can be analyzed starting 4 hours post-delivery.
Fig 5: PULSin® – Protocol
Delivery to a wide variety of cells
PULSin® is able to deliver proteins and antibodies to a large variety of cell lines and primary cells (Table 2, Fig. 1-3).
Table 2: Efficiency of R-phycoerythrin delivery using PULSin® in selected cells.
Highly efficient transfer
The comparison of PULSin® with two other protein delivery reagents shows a higher efficiency of protein delivery (Fig. 5). Moreover, the amount of protein delivered per cell is higher with PULSin® as measured for R-phycoerythrin protein and for FITC-alpha-tubulin antibody (Fig. 6).
Fig 6: Comparison of PULSin® efficiency with two other protein delivery reagents. R-phycoerythrin (1 µg) is complexed with each reagent according to the manufacturer’s protocol. Complexes are added to HeLa cells and observed by fluorescence microscopy over 24 hours.
Fig 7: FACS analysis of HeLa cells after delivery of R-phycoerythrin (upper graph) or FITC-anti-alpha-tubulin antibody (lower graph) with PULSin® or with competitor reagents B and C. Data are presented as histograms of the mean intensity of fluorescence for each cell population.
Mechanism of delivery
PULSin® contains a proprietary cationic amphiphile molecule that forms non-covalent complexes with proteins and antibodies.
Complexes are internalized via anionic cell-adhesion receptors and are released into the cytoplasm where they disassemble. The process is non-toxic and delivers functional proteins.
The intracellular delivery of proteins to live cells offers a powerful alternative as a scientific research tool where other approaches (DNA transfection, RNAi transfection) have failed.
The ability to introduce antibodies to live cells opens new insights to a wide range of applications such as protein intracellular trafficking studies, protein interference studies with blocking antibodies, live immunolabelling or protein phosphorylation states studies.
📰 Read Application note: Improving expression and purification of mAb using FectoCHO® Expression System and MabXpure™.
Every batch of PULSin® is tested by delivering R-phycoerythrin into HeLa cells.
PULSin® is provided as an aqueous solution in sterile and apyrogenic water. PULSin®, R-phycoerythrin and Hepes buffer are shipped at 4°C, should be stored at 4°C upon arrival, and as guaranteed by the Certificate of Analysis, will be stable for at least one year when stored appropriately.
Polyplus-transfection® has been awarded ISO 9001 Quality Management System Certification since 2002, which ensures that the company has established reliable and effective processes for manufacturing, quality control, distribution and customer support.
In order to download a product protocol or a certificate of analysis, please create an account on Polyplus-transfection® Portal.
Why would you need to create an account?
In this personal area you will have access to:
- Product Protocols
- Certificates of Analysis
- Exclusive webinars/articles
- And surprise features!
Related blog posts
|Cell Line||in vitro|
|Delivered Molecule||Reagent||Results & Citations|
Delehanty, J. B. et al. (2009)
Anal Bioanal Chem 393, 1091-105
Delivering quantum dots into cells: strategies, progress and remaining issues
|Mouse bone marrow-derived macrophages||in vitro||Protein/Peptide/Antibody||PULSin|
Nakahira, K. et al. (2011)
Nat Immunol 12, 222-30
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
Spagnolo, J. F. et al. (2010)
RNA 16, 382-93
Enzymatic and nonenzymatic functions of viral RNA-dependent RNA polymerases within oligomeric arrays
Cascella, R. et al. (2016)
J Biol Chem 291, 19437-48
Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies
Marchetti, C. et al. (2014)
J Cardiovasc Pharmacol 63, 316-322
A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse
Tazat, K. et al. (2019)
Cytoskeleton (Hoboken) 76, 123-130
Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-alpha7 to drive hypoxia-inducible factor (HIF)-1alpha nuclear translocation
Hu, X. et al. (2019)
Inflamm Res 68, 715-722
Anti-inflammatory activity of extensively hydrolyzed casein is mediated by granzyme B
|CHO, RAW 264.7||in vitro||Protein/Peptide/Antibody||PULSin|
Xiao YP. et al. (2020 )
Eur J Med Chem 207, 112799
Fluorinated polymer emulsion systems: Construction and application in delivering genes and proteins
Smethurst P. et al. (2020)
Brain 143, 430-440
Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis
Capitini, C. et al. (2014)
PLoS ONE 9, e86720
TDP-43 inclusion bodies formed in bacteria are structurally amorphous, non-amyloid and inherently toxic to neuroblastoma cells